Sangeeta Puri - Core Scientific, Vice Operations
| CORZZ Stock | 14.10 0.29 2.02% |
Executive
Sangeeta Puri is Vice Operations of Core Scientific, Tranche
| Address | 838 Walker Road, Dover, DE, United States, 19904 |
| Phone | 512 402 5233 |
| Web | https://corescientific.com |
Core Scientific, Management Efficiency
The company has return on total asset (ROA) of 0.0261 % which means that it generated a profit of $0.0261 on every $100 spent on assets. This is way below average. Core Scientific,'s management efficiency ratios could be used to measure how well Core Scientific, manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.04 in 2024, whereas Return On Tangible Assets are likely to drop (0.36) in 2024. At this time, Core Scientific,'s Intangible Assets are fairly stable compared to the past year. Total Assets is likely to rise to about 836.9 M in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 14.2 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| William CFA | Zscaler | N/A | |
| Crystal JD | Marqeta | 40 | |
| Randall Cook | BlackBerry | N/A | |
| Barbara Larson | SentinelOne | 53 | |
| Sanyogita Shamsunder | Nextnav Acquisition Corp | N/A | |
| Craig Gatarz | Veritone | 62 | |
| Larry Biagini | Zscaler | 65 | |
| Julie Harding | Veritone | N/A | |
| Fouzi Husaini | Marqeta | N/A | |
| Robert Schlossman | Zscaler | 56 | |
| Ashwin Kesireddy | Zscaler | N/A | |
| Divyasmita Ghatak | SentinelOne | 53 | |
| Alan Shapiro | DigitalOcean Holdings | 55 | |
| John Dimitropoulos | BlackBerry | N/A | |
| Jennifer ArmstrongOwen | BlackBerry | N/A | |
| Stacey Finerman | Marqeta | N/A | |
| Matthew OConnor | Veritone | N/A | |
| Remo Canessa | Zscaler | 67 | |
| Heather GanttEvans | Marqeta | N/A | |
| Maria Moore | Veritone | N/A | |
| David Knutson | Nextnav Acquisition Corp | 54 | |
Management Performance
| Return On Asset | 0.0261 |
Core Scientific, Tranche Leadership Team
Elected by the shareholders, the Core Scientific,'s board of directors comprises two types of representatives: Core Scientific, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Core. The board's role is to monitor Core Scientific,'s management team and ensure that shareholders' interests are well served. Core Scientific,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Core Scientific,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Adam Sullivan, President CEO | ||
| James Cleveland, Chief Officer | ||
| Cline Kezar, Head Operations | ||
| Larry Kom, Chief Officer | ||
| Michael Bros, Executive Strategy | ||
| Carol Haines, Head Policy | ||
| Darin Feinstein, Co Strategy | ||
| Denise Sterling, Executive CFO | ||
| Jay Brummett, Senior Construction | ||
| Denise CPA, Executive CFO | ||
| Russell Cann, Executive Services | ||
| Todd DuChene, Chief Officer | ||
| Jeff Taylor, Senior Officer | ||
| Matt Brown, Chief Officer | ||
| Steven Gitlin, Senior Relations | ||
| Lynn Burgener, Senior Trade | ||
| Aaron Mccreery, Executive Operations | ||
| Todd JD, Chief VP | ||
| Sangeeta Puri, Vice Operations | ||
| Sharon Orlopp, Chief Officer | ||
| Jeff Pratt, Senior Partnerships | ||
| Scott Brueggeman, Chief Officer |
Core Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Core Scientific, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0261 | ||||
| Profit Margin | (2.23) % | ||||
| Operating Margin | (0.43) % | ||||
| Number Of Shares Shorted | 43.66 K | ||||
| Revenue | 502.4 M | ||||
| EBITDA | (63.12 M) | ||||
| Net Income | (246.49 M) | ||||
| Total Debt | 865.54 M | ||||
| Book Value Per Share | (2.61) X | ||||
| Cash Flow From Operations | 65.11 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.